🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry 🔓 Open Access bit.ly/45Ib3U7

In Clinical Infectious Diseases, Lise Cuzin, MD, (@maman_poissons) & colleagues describe the median time from #HIV diagnosis to controlled viral load (VL), as well as median times between each step of the cascade, over time between 2009 & 2019. Read: idsajournals.link/Egq8Ss

If you are interested in the CICU or crit care cards, there are many pathways. Finding the right one for you is key, and developing new ones is even more important! pubmed.ncbi.nlm.nih.gov/37695412/@CCFc… CCF Pulmonary and Critical Care Fellows Aniket Rali, MD, FACC, FCCP Jason N. Katz Ann Gage Elliott Miller Carlos L. Alviar MD, FACC Sarah Gorgis, MD

Weight and body composition changes in the first year following ART initiation are associated with contemporaneous changes in metabolic parameters and subsequent cardiometabolic disease. Learn more ⬇️ ✅ Just Accepted 🆓 Freely Available bit.ly/3PBa7LD

Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study 🔗 bit.ly/3PlGoVR

A fantastic #tidbit #graphicalabstract made by Simon Feys published in Clinical Infectious Diseases!

This week’s most viewed articles: 1. Asthma in Adults nej.md/3ECJwaT #pulmonology #CriticalCare

Interesting study!

Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis ✅ Just Accepted 🔓 Open Access bit.ly/3PMLFpG

🚨 We're only 65 followers away from hitting our goal of 10k! Please share this and help us get the word out so we can break the 5-digit follower mark before #IDWeek2023! 🚨

Community-acquired #pneumonia (CAP) is associated with high morbidity and mortality. In Clinical Infectious Diseases, Anselm Jorda, MD, and colleagues aimed to assess the effect of #corticosteroids on all-cause mortality in patients hospitalized with CAP. Read: idsajournals.link/Uiaftg

Science: the process of understanding the world through experimentation and observation Belief: feelings that something is true Unscientific belief: something is held as a generalizable fact without substantial scientific supporting evidence

Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipients bit.ly/3Q0uDo4

Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials ✅ Just Accepted bit.ly/3QCLVJC

Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis 🔓 Open Access bit.ly/3PMLFpG

Reducing HIV-associated post-hospital mortality through home-based care in South Africa: a randomized controlled trial Clinical Infectious Diseases IDSA tidbitapp.io/tidbits/reduci…

Recently published: The Comparative Effectiveness of Fidaxomicin compared to Vancomycin in Populations with Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection, a single center study tidbitapp.io/tidbits/the-co…

Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis tidbitapp.io/tidbits/age-sp…

In Clinical Infectious Diseases, Melisa Shah, MD, and colleagues estimated the stepwise benefit of monovalent vaccination and Paxlovid (nirmatrelvir-ritonavir) against COVID-19 hospitalization in the United States. Read: idsajournals.link/sW7qkZ

The generation of a stable long-lived plasma cell (LLPC) population is required for durable antibody responses. In Journal of Infectious Diseases, Zahra Tehrani, PhD, and colleagues aim to study bone marrow LLPCs against antigens whose antibody responses last for decades (tetanus) or wanes rapidly